MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s40292-023-00618-w

Медицинская библиотека · High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2024

Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry.

Parra Ramírez Paola, Martín Rojas-Marcos Patricia, Paja Fano Miguel, González-Boillos Margarita, Pascual-Corrales Eider, García Cano Ana María, Ruiz-Sanchez Jorge Gabriel, Vicente Delgado Almudena, Gómez Hoyos Emilia, Ferreira Rui, García Sanz Iñigo, Recasens Sala Mònica, Barahona San Millan Rebeca, Picón César María José, Díaz Guardiola Patricia, Perdomo Carolina M, Manjón-Miguélez Laura, Rebollo Román Ángel, Robles Lázaro Cristina, Morales-Ruiz Manuel, Calatayud María, Andree Furio Collao Simone, Meneses Diego, Sampedro-Nuñez Miguel Antonio, Mena Ribas Elena, Sanmartín Sánchez Alicia, Gonzalvo Diaz Cesar, Lamas Cristina, Guerrero-Vázquez Raquel, Del Castillo Tous María, Serrano Gotarredona Joaquín, Michalopoulou Alevras Theodora, Tenés Rodrigo Susana, Roa Chamorro Ricardo, Jaen Aguila Fernando, Moya Mateo Eva María, Hanzu Felicia A, Araujo-Castro Marta

Многоцентровое исследованиеСтатьяПеревод в очереди

Аннотация

INTRODUCTION

Primary aldosteronism (PA) is associated with several cardiometabolic comorbidities. Specific treatment by mineralocorticoid receptor antagonists (MRA) or adrenalectomy has been reported to reduce the cardiometabolic risk. However, the cardiovascular benefit could depend on plasma renin levels in patients on MRA.

AIM: To compare the development of cardiovascular, renal and metabolic complications between medically treated patients with PA and those who underwent adrenalectomy, taking the renin status during MRA treatment into account.

METHODS

A multicenter retrospective study (SPAIN-ALDO Register) of patients with PA treated at 35 Spanish tertiary hospitals. Patients on MRA were divided into two groups based on renin suppression (n = 90) or non-suppression (n = 70). Both groups were also compared to unilateral PA patients (n = 275) who achieved biochemical cure with adrenalectomy.

RESULTS

Adrenalectomized patients were younger, had higher plasma aldosterone concentration, and lower potassium levels than MRA group. Patients on MRA had similar baseline characteristics when stratified into treatment groups with suppressed and unsuppressed renin. 97 (55.1%) of 176 patients without comorbidities at diagnosis, developed at least one comorbidity during follow-up (median 12 months vs. 12.5 months' follow-up after starting MRA and surgery, respectively). Surgery group had a lower risk of developing new cardiovascular events (HR 0.40 [95% CI 0.18-0.90]) than MRA group. Surgical treatment improved glycemic and blood pressure control, increased serum potassium levels, and required fewer antihypertensive drugs than medical treatment. However, there were no differences in the cardiometabolic profile or the incidence of new comorbidities between the groups with suppressed and unsuppressed renin levels (HR 0.95 [95% CI 0.52-1.73]).

CONCLUSION

Cardiovascular, renal, and metabolic events were comparable in MRA patients with unsuppressed and suppressed renin. Effective surgical treatment of PA was associated with a decreased incidence of new cardiovascular events when compared to MRA therapy.

Для цитирования: Parra Ramírez Paola, Martín Rojas-Marcos Patricia, Paja Fano Miguel, González-Boillos Margarita, Pascual-Corrales Eider, García Cano Ana María, Ruiz-Sanchez Jorge Gabriel, Vicente Delgado Almudena, Gómez Hoyos Emilia, Ferreira Rui, García Sanz Iñigo, Recasens Sala Mònica, Barahona San Millan Rebeca, Picón César María José, Díaz Guardiola Patricia, Perdomo Carolina M, Manjón-Miguélez Laura, Rebollo Román Ángel, Robles Lázaro Cristina, Morales-Ruiz Manuel, Calatayud María, Andree Furio Collao Simone, Meneses Diego, Sampedro-Nuñez Miguel Antonio, Mena Ribas Elena, Sanmartín Sánchez Alicia, Gonzalvo Diaz Cesar, Lamas Cristina, Guerrero-Vázquez Raquel, Del Castillo Tous María, Serrano Gotarredona Joaquín, Michalopoulou Alevras Theodora, Tenés Rodrigo Susana, Roa Chamorro Ricardo, Jaen Aguila Fernando, Moya Mateo Eva María, Hanzu Felicia A, Araujo-Castro Marta. Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry.. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension. 2024. DOI: 10.1007/s40292-023-00618-w.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.